1. Home
  2. CERT vs AAPG Comparison

CERT vs AAPG Comparison

Compare CERT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERT
  • AAPG
  • Stock Information
  • Founded
  • CERT 2008
  • AAPG 2009
  • Country
  • CERT United States
  • AAPG China
  • Employees
  • CERT N/A
  • AAPG N/A
  • Industry
  • CERT Retail: Computer Software & Peripheral Equipment
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • CERT Technology
  • AAPG Health Care
  • Exchange
  • CERT Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • CERT 2.3B
  • AAPG 2.2B
  • IPO Year
  • CERT 2020
  • AAPG 2025
  • Fundamental
  • Price
  • CERT $11.36
  • AAPG $24.40
  • Analyst Decision
  • CERT Buy
  • AAPG Buy
  • Analyst Count
  • CERT 6
  • AAPG 1
  • Target Price
  • CERT $15.60
  • AAPG N/A
  • AVG Volume (30 Days)
  • CERT 1.7M
  • AAPG 14.1K
  • Earning Date
  • CERT 05-05-2025
  • AAPG 06-10-2025
  • Dividend Yield
  • CERT N/A
  • AAPG N/A
  • EPS Growth
  • CERT N/A
  • AAPG N/A
  • EPS
  • CERT N/A
  • AAPG N/A
  • Revenue
  • CERT $394,498,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • CERT $11.47
  • AAPG N/A
  • Revenue Next Year
  • CERT $9.03
  • AAPG $389.09
  • P/E Ratio
  • CERT N/A
  • AAPG N/A
  • Revenue Growth
  • CERT 9.37
  • AAPG 341.77
  • 52 Week Low
  • CERT $8.64
  • AAPG $16.50
  • 52 Week High
  • CERT $17.76
  • AAPG $26.55
  • Technical
  • Relative Strength Index (RSI)
  • CERT 41.96
  • AAPG N/A
  • Support Level
  • CERT $11.17
  • AAPG N/A
  • Resistance Level
  • CERT $11.75
  • AAPG N/A
  • Average True Range (ATR)
  • CERT 0.42
  • AAPG 0.00
  • MACD
  • CERT -0.06
  • AAPG 0.00
  • Stochastic Oscillator
  • CERT 24.00
  • AAPG 0.00

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: